"Cardiovascular Disease Risk Assessment Systems And Uses Thereof" in Patent Application Approval Process (USPTO 20230402183).
In: Drug Week, 2024-01-05, S. 1089-1089
serialPeriodical
Zugriff:
A patent application has been filed for a system that can predict cardiovascular disease (CVD) risk in individuals with normal lipid profiles or those undergoing lipid management therapy. The system involves characterizing genetic information obtained from sequencing data of monocytes and applying a logistic regression model to estimate the probability of a cardiovascular event. The system also includes comparing the genetic information to a candidate gene set associated with functions such as inflammation, immune response, lipid transport, metabolism, and cell proliferation. This technology could address the need for effective risk assessment in populations where current systems are not accurate. [Extracted from the article]
Copyright of Drug Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
"Cardiovascular Disease Risk Assessment Systems And Uses Thereof" in Patent Application Approval Process (USPTO 20230402183).
|
---|---|
Zeitschrift: | Drug Week, 2024-01-05, S. 1089-1089 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1531-6440 (print) |
Sonstiges: |
|